From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.
Scott Milligan, PhD
Advertisement
Articles by Scott Milligan, PhD
Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.
A statewide collaboration between payers and providers to create a cancer clinical care pathways program is successful.
Advertisement
Latest Updated Articles
- Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
Published: July 12th 2019 | Updated:
- Implementation of Cancer Clinical Care Pathways: A Successful Model of Collaboration Between Payers and Providers
Published: May 18th 2012 | Updated:
- Implementation of Cancer Clinical Care Pathways
Published: September 18th 2012 | Updated:
- Third-Party Validation of Observed Savings From an Oncology Pathways Program
Published: June 18th 2013 | Updated:
- Physician Behavior Impact When Revenue Shifted From Drugs to Services
Published: April 21st 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV
4
Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes
5
